Skip to main content

Table 1 Literatures about Candida- associated pulmonary valve endocarditis

From: A chronic hemodialysis patient with isolated pulmonary valve infective endocarditis caused by non-albicans Candida: a rare case and literature review

  Patient (age/gender) Risk Factor Presentation Candida Surgical management Antibiotics use and duration Outcome
Devathi et al. [4] 61/ male 1. Intravenous drug abuser. 2. Transient neutropenia Hypoxemic respiratory failure; pulmonary valve vegetation 1.5 cm. Candida albicans Not performed Liposomal amphotericin B for 8 weeks No recurrence in 6 months.
Uchida et al. [13] 66/ male Staphylococcus aureus sepsis with exposure to broad spectrum antibiotics Multifocal pulmonary embolism and severe pulmonary regurgitation. Candida parapsilosis Resection of pulmonary valve without replacement. Amphotericin B for 8 weeks. Severe pulmonary regurgitation 2 years after operation.
Darwanzah et al. [11] 17/ male 1. Patent Ductus arteriosus.
2. Visceral Leishmaniasis in bone marrow.
3. Prolonged intravenous injection of antibiotics and fluid.
1. Congestive heart failure
2. Acute renal failure with HD.
3. Pulmonary valve vegetation 0.9 cm.
Candida albicans 1. Resection of pulmonary valve with repairment.
2. Ligation of PDA.
Amphotericin B No recurrence in 2 years.
Hou et al. 63/ female 1. Tunneled-cuff catheter
2. Monoclonal gammapathy
3. Chronic HD.
4. Liver cirrhosis
1. Persistent fungemia
2. Splenic infarction.
Candida guilliermondii N/A Fluconazole for 8 weeks. Caspofungin for 8 weeks followed by fluconazole 200 mg daily. Expired